Bruce Stephens
Well-Known Member
- Relationship to Diabetes
- Type 1
I don't know, but my suspicion is that when the NHS negotiate a price for medications and treatments etc. it is on the understanding that these will be prescription-only items so the companies do not forfeit potential profits from individuals who self-fund.
In this particular case some pharmacies were (maybe some still are) selling at £35. That presumably means they were selling at a loss but I thought the loss was just their costs and profit (i.e., £35 is the wholesale price). And the NHS deal was that price but also with some test strips thrown in (and presumably the Reader too). (As part of the 6-month trial the prescription I got was for 3 sensors and 50 test strips, so maybe that's the deal: 50 free test strips with 3 sensors?)
Regardless, I'll bet Abbott wouldn't mind at all if the NHS decided to offer the sensors to any T1 who wanted them (or T2, for that matter).
(If that's the case maybe one can argue that the NHS's negotiating wasn't that effective.)